Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer...
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia60 moreThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
LymphomaMalignant Solid Neoplasm5 moreThis research trial collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
Lymphoblastic LymphomaRetrospective observational study with systematic collection of data on filiation (age at diagnosis and sex), clinical data (IPI, ECOG, early response to chemotherapy, overall response to chemotherapy), biological (strain B or T, infiltration of the nervous system central [CNS], bone marrow [MO], lactate dehydrogenase (LDH) level at the time of diagnosis, as well as genetic patients included in the study, as well as the PETHEMA protocol used in the treatment of same patients The study will review the PETHEMA protocols from 2003 to the present
Tissue Collection for Studies of Lymph Cancer
Hodgkin DiseaseLymphoma5 moreBackground: - Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, and adult leukemia/lymphoma. The samples collected will include blood, urine, bone marrow, and tumor and skin tissue. Objectives: - To collect tissue samples to study different types of lymph cancer. Eligibility: - Individuals at least 18 years of age who have a lymphoid cancer or precancer condition. Design: Participants will be screened with a physical exam and medical history. Different samples will be collected for study. Blood samples will be collected at the initial testing. More blood samples will be collected at different treatment points. Other liquid samples include urine, bone marrow, and any abnormal fluid. Tumor tissue and skin tissue biopsies will also be collected for study. Treatment will not be provided as part of this study.
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
LeukemiaLymphomaThis trial collects feedback from patients to develop a video game in improving the outcomes in stem cell transplant survivors. A video game may help to improve health behaviors for leukemia or lymphoma patients after stem cell transplant.
Institut Paoli Calmettes Lymphoma Database
LymphomaDatabase of Institut Paoli-Calmettes patients diagnosed with lymphoma
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden...
LymphomaMantle-CellThe purpose of this study is to investigate and characterize the association of lenalidomide with tumor flare reaction and high tumor burden in participants with relapsed or refractory mantle cell lymphoma.
Characterization of the Microbiome in Cutaneous T Cell Lymphoma
Cutaneous T Cell LymphomaInvestigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.
Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma
Natural Killer T-cell LymphomaThe purpose of this study is to determine the Predictive value of a SNP signature and liquid biopsy in patients with natural killer T-cell lymphoma.
Quality of Life in Lymphoma Patients One Year Post-chemotherapy
LymphomaMalignant lymphomas are considered as among the most chemo-sensitive cancers. ML are cured in more than 85% of patient, the majority with complete response. After this active phase of treatment, patients are in "after cancer period". Toulouse University Hospital developed since 2006 the Ambulatory Medical Assistance for After Cancer program on lymphoma patient. Ambulatory Medical Assistance for After Cancer is very efficient for detecting physical and psychological complications which impact quality of life. The investigators identified 22% of lymphoma patients who had a reduced quality of life one year after the end of chemotherapy. The present study aims to investigate the evolution of observed complications and identify cancer care pathway which decrease the quality of life reduction risk in patients one year after lymphoma chemotherapy.